SCHEMBL7105579

SCHEMBL7105579

CCN(CC)c1c(N[C@@H](Cc2ccc(Nc3ccnc4ccccc34)cc2)C(=O)O)c(=O)c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 12/20 0.60
ITGA4 P13612 12/20 0.60
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
DNMT1 P26358 3/20 0.43
DNMT3A Q9Y6K1 3/20 0.43
HDAC3 O15379 1/20 0.43
ACHE P22303 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
DNMT3L Q9UJW3 1/20 0.43
MAPKAPK2 P49137 1/20 0.43
MITF O75030 1/20 0.41
RAD52 P43351 1/20 0.41
ERBB2 P04626 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7099956 0.86 ITGB1 (0.57) ITGB1ITGA4HDAC3HDAC1HDAC7
SCHEMBL7104336 0.84 ITGB1 (0.60) ITGB1ITGA4
SCHEMBL7718529 0.79 ITGB1 (0.77) ITGB1ITGA4
SCHEMBL7710752 0.78 ITGB1 (0.54) ITGB1ITGA4
SCHEMBL7105057 0.78 ITGB1 (0.52) ITGB1ITGA4
SCHEMBL7259001 0.78 ITGB1 (0.52) ITGB1ITGA4
SCHEMBL7259610 0.78 ITGB1 (0.58) ITGB1ITGA4
SCHEMBL7258653 0.78 ITGB1 (0.56) ITGB1ITGA4
SCHEMBL7100149 0.78 ITGB1 (0.52) ITGB1ITGA4
SCHEMBL7264263 0.78 ITGB1 (0.52) ITGB1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162799-A1 Carbocyclic oxo, carboxy amines such as 3-(4-(3,5-Dichloro-4-pyridylcarboxamido)phenyl)-2-(2-propylamino-3,4 -dioxocyclobut-1-enyl)amino)propanoic acid, used as integrin antagonists; antiinflammatory agents CELLTECH R&D LIMITED (GB) 2003-08-28 US disclosed
US-6518283-B1 To modify integrin function in such a way as to beneficially modulate cell adhesion CELLTECH R&D LIMITED (GB) 2003-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162799-A1 Carbocyclic oxo, carboxy amines such as 3-(4-(3,5-Dichloro-4-pyridylcarboxamido)phenyl)-2-(2-propylamino-3,4 -dioxocyclobut-1-enyl)amino)propanoic acid, used as integrin antagonists; antiinflammatory agents ICAM1, VCAM1, CCR1 ITGB1 5/4885ITGA4 28/4885HTR2C 3262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.